INMBNasdaq United States
Market cap
$55.430 M
$2.09 +9.16%
Close of 7 Aug 2026
Revenue
$50.0K
#3629 by revenue
Earnings
-$46.0M
Loss-making
Shares outstanding
27,753,789
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Inmune Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.